SlideShare a Scribd company logo
1 of 48
Prevention of allergy
Where are we in 2015 ?
Dr Masy Nadine
European Exam in Allergology
UEMS Examination EAACI
Certificate of excellence in Allergology and Clinical
Immunology
Berlin, 17th of november 2015
Allergy Course
“Targets for Prevention”
The gut microbiota :
in the early development of both local and systemic immune maturation and programming
Studies on prevention :
1. The gut microbiota its localisation
Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and DiseaseChristina L. Ohland1 and Christian Jobin1,2
(Cell Mol Gastroenterol Hepatol 2015;1:28–40
Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and DiseaseChristina L. Ohland1 and Christian Jobin1,2
(Cell Mol Gastroenterol Hepatol 2015;1:28–40
Studies on prevention :
2. The gut microbiota and intestinal
homeostasis
The gut microbiota :
in the early development of both local and systemic immune maturation and programming
Studies on prevention :
3. The gut microbiota and fiber diet
Increase in dietary fiber dampens allergic responses in the lung. Gary B Huffnagle. Nature Medicine 20, 120–121
(2014
The immune system and the
gut microbiota: friends or
foes? N. Cerf-Bensussan,
V.Gaboriau-Routhiau.
Nature Reviews Immunology
10, 735-744 (October 2010)
Studies on prevention :
4. The gut microbiota and altered host system
Studies on prevention :
5. The gut microbiota of the pregnant woman
Gut microbiota and allergy: the importance of the pregnancy period
Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm
Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165
A possible route for bacteria originating from the gut to reach the placental tissue during pregnancy.
Dendritic cells (DCs) actively penetrate the epithelium, sample the microbes within the gut lumen, and
transport them to the placenta…
Studies on prevention :
6. The gut microbiota of the pregnant woman
Epigenetic changes of the promoter region of immunoregulatory genes important for allergy development could explain how
the effect of microbial exposure to the mother during or even before pregnancy is transferred to the next generation…
Gut microbiota and allergy: the importance of the pregnancy period
Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm
Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165
Studies on prevention :
7. The gut microbiota of the pregnant woman
There is a temporal dissociation between the major changes in microbial exposure to children in westernized
countries, which occurred during the first half of the century, and the onset of the accelerating increase in allergic
diseases…
Gut microbiota and allergy: the importance of the pregnancy period
Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm
Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165
Seventeen studies, reporting data from 4755 children
(2381 in the probiotic group and 2374 in the control group)
Infants treated with probiotics had a significantly lower RR for eczema compared to controls.
No significant dif- ference in terms of prevention of asthma or rhinoconjunctivitis
The results of the meta-analysis show that probiotic supplementation prevents infantile eczema, thus
suggesting a new potential indication for probiotic use in pregnancy and infancy.
Studies on prevention :
8. Probiotics started prenatally and in combination with
breastfeeding
and it is mainly probiotics started prenatally and in combination with breastfeeding,
showing the best effectiveness
Gut microbiota and allergy: the importance of the pregnancy period
Zuccotti G, Meneghin F, Aceti A, Barone G, et al. Probiotics for prevention of atopic diseases in infants: systemic review and meta-analysis. Allergy
2015: 70: 1356–71.
In a recent large meta-analysis performed on 25 trials,
the authors concluded that a prenatal and/or early-life probi-
otic
Lactobacillus, Bifidobacterium, and Saccharomyces
administration reduces the risk of atopic sensitization
but may not reduce the risk of asthma/wheezing.
Studies on prevention :
9. Probiotics started prenatally and in combination with
breastfeeding
Dugoua J-J, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta- analysis of
randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can 2009;31:542–552.
Studies on prevention :
10. Microbial exposure and colonization
Promising candidates for allergy preventionJames E. Gern, MD, FAAAAIMadison, Wis J Allergy Clin Immunol 2015;136:23-8.)
Studies on prevention :
11. Epigenetics and farm exposure in childhood
Michel S, Busato F, Genuneit J, et al. Farm exposure and time trends in early childhood may influence DNA
methylation in genes related to asthma and allergy. Allergy 2013;68:355–64.
Farming seems to influence methylation in a
number of the genes and gene families.
It suggests the feasibility of such studies in
asthma, and it highlights that a strong
protective environmental factor, such as
growing up on a farm, which is associated with
disease development influences methylation
and that timing of DNA collection for analysis is
crucial
Studies on prevention :
12. Early moisturizing in infants at risk for
atopic dermatitis
Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin
Immunol 2014: 134: 818–23.DU TEXTE DE
Horimukai K, Morita K, Narita M, Kondo M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014: 134: 824–
30.
Studies on prevention :
13. Early moisturizing in infants at risk for
atopic dermatitis
Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic
dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63.
Effects of Vitreoscilla filiformis treatment on atopic
dermatitis lesions. (Gram-negative aerobic bacterium)
Patients treated
(a)with placebo
(b) with V. filiformis lysate
before and on day 29 of treatment.
Studies on prevention :
14. Early moisturizing with
bacterial products
Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic
dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63.
Effects of Vitreoscilla filiformis treatment on pruritus.
The mean visual analogue scale (VAS) score for
pruritus by visit and treatment group with its 95%
confidence interval.
Compared with baseline a significant decrease was
observed only in the V. filiformis group (verum),
already by day 15 (P < 0·0002) and on day 29
(P < 0·0001).
The between-group difference concerning pruritus
VAS endpoint was also significant on day 29
(P = 0·017) as well as the course of pruritus
development (the time by treatment interaction;
P = 0·008).
Studies on prevention :
15. Early moisturizing with bacterial products
Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic
dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63.
Effects of Vitreoscilla filiformis
treatment on SCORing of
Atopic Dermatitis (SCORAD).
Compared with baseline a
significant decrease was
observed only in the
V. filiformis group (verum),
Studies on prevention :
16. Early moisturizing with bacterial products
Studies on prevention :
17. Studies on weaning
Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin
Immunol 2008: 122: 984–91.
In one study, it was found
that the risk of peanut
allergy was 10 times higher
among Jewish children in UK,
compared to Israeli children
of similar ancestry, which
was attributed to the early
introduction of peanuts in
the Israeli children
Studies on prevention :
18. Studies on weaning : peanut
Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin
Immunol 2008: 122: 984–91.
UK UK ISRAEL
Studies on prevention :
19. Studies on weaning : Israelic children
Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin
Immunol 2008: 122: 984–91.
Studies on prevention :
20. Studies on weaning : peanut consumption
Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N
Engl J Med 2015: 372: 803–13.
The British LEAP study (Learning Early About Peanut Allergy),
640 ‘high-risk’ babies (defined as those with egg allergy, severe eczema or both)
The infants were assigned to two groups: those whose parents were to regularly
feed them peanut and those whose parents were told to have their children avoid
peanut altogether.
The children, enrolled between the ages of 4 and 11 months, were given a
conclusive peanut food challenge at age 5.
At that age, on average, only 3.2% of the ‘consumption’ group had developed a
peanut allergy, compared to more than 17.2% in the ‘avoidance’ group. They
reported that in the peanut consumption group, at a high risk of developing
allergy, showed a reduction of the odds that a peanut allergy will develop by a
remarkable 70–80%.
The results of the study have huge implications on the early
introduction of allergic foods to prevent food allergy.
YES NO
Studies on prevention :
21. Guidelines of the AAAAI
early peanut introduction
J Allergy Clin Immunol 2015;136:258-61
The American Academy of Allergy, Asthma
and Immunology (AAAAI) implemented the
study in their new guidelines on allergy
prevention
Studies on prevention :
22. Early exposure to cow’s milk protein
Katz Y, Rajuan N, Goldberg MR, et al. Early exposure to cow’s milk protein is protective against IgE-mediated cow’s milk protein
allergy. J Allergy Clin Immunol 2010: 126: 77–82.
Supplementation at birth with CMP (cow’s milk protein) should be
recommended to promote its tolerance. For those patients with IgE-
mediated CMP allergy, soy is a reasonable feeding alternative.
Studies on prevention :
23. Studies on weaning : early egg introduction
Palmer DJ, Metcalfe J, Makrides M, et al. Early regular egg exposure in infants with eczema: a randomized
controlled trial. J Allergy Clin Immunol 2013: 132: 387–92.
Studies on prevention :
24. Studies on weaning : early egg introduction
Palmer DJ, Metcalfe J, Makrides M, et al. Early regular egg exposure in infants with eczema: a randomized
controlled trial. J Allergy Clin Immunol 2013: 132: 387–92.
Induction of immune tolerance pathways and reduction in the egg allergy rate can
be achieved by early regular oral exposure to egg
• from 4 months of age
• in infants with moderate-to-severe eczema.
The earlier introduction of egg in solid foods does not appear to increase the risk
of egg allergy in this high-risk group.
However, caution needs to be taken when these high-risk infants are first exposed
to egg because many have sensitization already and clinical reactivity by 4 months
of age. This points to much earlier events in the initiation of food sensitization, well
before the introduction of complementary feeding.
Clinical implications: Caution needs to be taken when infants with moderate-to-
severe eczema are first exposed to egg because many have sensitization already
and clinical reactivity by 4 months of age.
Studies on prevention :
25. Studies on weaning :
early egg introduction (Melbourne, Australia)
Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg
prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13.
the observational Australian HealthNuts study suggested that first exposure to more
allergenic (unbaked) egg was more likely to reduce the egg allergy risk
Studies on prevention :
26. Studies on weaning :
early egg introduction (Melbourne, Australia)
Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg
prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13.
Studies on prevention :
27. Studies on weaning : early egg introduction
(Melbourne, Australia)
Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg
prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13.
The observational Australian HealthNuts study suggested that
first exposure to more allergenic (unbaked) egg was more likely to reduce the egg allergy
risk
In low-allergy risk infants Baked eggs : cake and biscuits Cooked eggs = hard-boiled,soft-boiled, fried or poached eggs
Studies on prevention :
28. Studies on breastfeeding:
Peroni DG, Pescollderungg L, PiacentiniGL, et al. Immune regulatory cytokines in the milk of lactating women
from farming and urban environments. Pediatr Allergy Immunol 2010: 21: 977–82.
Studies on prevention :
29. Studies on breastfeeding:
Peroni DG, Pescollderungg L, PiacentiniGL, et al. Immune regulatory cytokines in the milk of lactating women
from farming and urban environments. Pediatr Allergy Immunol 2010: 21: 977–82.
Studies on prevention :
30. Studies on hypo-allergenic milks :
• von Berg A, Filipiak-Pittroff B, Kramer U, Link E, et al. Preventive effect of hydrolyzed infant formulas persists
until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin
Immunol 2008: 121: 1442–7.
Studies on prevention :
31. Studies on hypo-allergenic milks :
• Nieto A, Wahn U, Bufe A, Eigenmann P, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol
2014: 25: 516–33.
Studies on prevention :
32. Studies on hypo-allergenic milks :
Nieto A, Wahn U, Bufe A, Eigenmann P, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol
2014: 25: 516–33.
Studies on prevention :
33. Studies on the gut microbiome in pregnancy:
Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic
changes during pregnancy. Cell 2012: 150: 470–80.
T1 Trimester 1
T3 Trimester 3
Studies on prevention :
34. Studies on the gut microbiome in pregnancy:
Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic
changes during pregnancy. Cell 2012: 150: 470–80.
Actinobacteria (which includes Bifidobacteria) and Proteobacteria
seem to undergo a significant distributive change in the last
trimester of pregnancy, and it could be that focussing on
Bifidobacteria is a better way to go
Perhaps probiotics need to be started earlier in pregnancy (from the
onset?), as the dynamics of the own microbiota, changing from the
beginning of pregnancy, have been shown.
Unfortunately, there are no comparative studies of microbiota
during pregnancy between allergic and non-allergic women.
Studies on prevention :
35. Studies on immunotherapy :
Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis:
a systematic review and meta-analysis of randomized control trials. J Allergy Clin Immunol 2013: 132: 110–7.
Studies on prevention :
36. Studies on immunotherapy :
Prevention of New Sensitizations by Specific Immunotherapy in Children With Rhinitis and/or Asthma
Monosensitized to House Dust Mite. J Investig Allergol Clin Immunol 2007; Vol. 17(2): 85-91
Effect on
SIT on the
medication
score
Studies on prevention :
37. Studies on food immunotherapy :
OIT for
peanut
OIT can result in desensitisation in children, and that this is
associated with evidence of underlying immune-modulation.
However, this treatment approach was associated with a
substantial risk of adverse events, although the majority of
these were mild.
In view of the risk of adverse events and the lack of evidence of
long-term benefits, allergen-specific peanut OIT cannot currently
be recommended as a treatment for the management of
patients with IgE-mediated peanut allergy.
Larger RCTs are needed to investigate the acceptability, long-
term effectiveness and cost-effectiveness of safer treatment
regimens, particularly in relation to the induction of clinical and
immunological tolerance.
Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for
peanut allergy. Cochrane Database Syst Rev 2012: 9: CD009014.
Studies on prevention :
38. Studies on food immunotherapy :
Tang ML, Ponsonby AL, Orsini F, et al. Administration of a probiotic with peanut oral immunotherapy: a
randomized trial. J Allergy Clin Immunol 2015: 135: 737–44.
OIT for
peanut
and
probiotics
This is the first randomized placebo-controlled trial
evaluating the novel co-administration of probiotic and
peanut OIT and assessing for sustained unresponsiveness
in children with peanut allergy.
PPOIT was effective in inducing two-week sustained
unresponsiveness, and immune changes that likely reflect
reprogramming of the peanut- specific immune response.
Further work is required to confirm sustained
unresponsiveness after a longer period of secondary
peanut elimination and to clarify the relative contributions
of probiotic vs OIT.
Studies on prevention :
39. Studies on immunotherapy :
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.
Allergy, Volume 70, Issue 6, June 2015, Pages: 707–710, G. Senti, S. von Moos, F. Tay, N. Graf, P. Johansen and
T. M. Kündig
Epicutaneous
immunotherapy
Prior to the pollen season 2009,
patients received six patches (allergen extract: n = 48;
placebo: n = 50) with
weekly intervals, administered onto tape-stripped skin.
Allergen EPIT produced a
median symptom improvement of 48% in 2009 and 40% in
the treatment-free follow-up year 2010 as compared to
10% and 15% improvement after placebo
EPIT (P = 0.003).
After allergen EPIT but not placebo EPIT, conjunctival
allergen reactivity was significantly decreased and allergen-
specific IgG4 responses
were significantly elevated (P < 0.001).
Studies on prevention :
40. Studies on immunotherapy :
Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model. Allergy,
Volume 67, Issue 5, May 2012, Pages: 622–629, W. Li, Z. Zhang, A. Saxon and K. Zhang
Epicutaneous
immunotherapy
with food in a
mouse model Treg
Mondoulet L, Dioszeghy V, Puteaux E, et al. Specific epicutaneous immunotherapy prevents sensitization to
new allergens in a murine model. J Allergy Clin Immunol 2015: 135: 1546–57.
Epicutaneous
immunotherapy
with food in a
mouse model
(EPIT)
Treg
Studies on prevention :
41. Studies on immunotherapy :
Studies on prevention :
42. Studies on immunotherapy :
Chang YC, Chow YH, Sun HL, et al. Alleviation of respiratory syncytial virus replication and inflammation by
fungal immunomodulatory protein from Flammulina velutipes. Antiviral Res 2014: 110: 124–31.
• Non-specific IT, using Th1 or Treg cell stimulants, such as
bacterial antigens, should also become a subject of research
in primary prevention.
• One example is the anti-inflammatory and inhibitory
effect on RSV replication of the golden needle mushroom
(Flammulina velutipes)
Non-specific
immunotherapy
using Th1 or Treg
cell stimulants
Non-specific
immunotherapy
FIP-fve proteinFlammulina velutipes
Studies on prevention :
43. Studies on immunotherapy :
Mpairwe H, Webb EL, Muhangi L, et al. Antihelminthic treatment during pregnancy is associated with
increased risk of infantile eczema: randomized-controlled trial results. Pediatr Allergy Immunol 2011: 22: 305–
12.
Non-specific immunotherapy ,
using immunomodulating
agents like helminths during
pregnancy
Schistosoma
mansoni
Decreased
risk of
eczema in
infants
Studies on prevention :
44. Studies on immunotherapy :
Mpairwe H, Webb EL, Muhangi L, et al. Antihelminthic treatment during pregnancy is associated with
increased risk of infantile eczema: randomized-controlled trial results. Pediatr Allergy Immunol 2011: 22: 305–
12.
Antihelminthic treatment
of pregnant African mothers with
Schistosoma mansoni
Schistosoma
mansoni
Praziquantel
Increased
risk of
eczema in
infants
Albendazole
Studies on prevention :
45. Studies on immunotherapy :
In utero priming by worms protects against respiratory allergies. Hermelijn H. Smits, Cezmi A. Akdis. Journal
of Allergy and Clinical Immunology, Vol. 134, Issue 6, p 1280–1281
In utero
priming by
Schistosoma
mansoni
They are three types of primary prevention strategies
- early administration of bacterial products (most studies are on probiotics)
- early moisturizing in infants at risk for atopic dermatitis
- early exposure to allergenic foods (studies are on milk,peanut and egg)
- the use of immunotherapy
- the use of immunomodulatory treatments (mushrooms proteins, worms
products...)
 much more research needs to be carried out
 we have to define what advice can really be given in clinical practice
Take home messages
on prevention in allergy
Berlin, 17th of november 2015
Allergy Course
“Targets for Prevention”
Thank you
Dr Masy Nadine
European Exam in Allergology
UEMS Examination EAACI
Certificate of excellence in Allergology and Clinical
Immunology
Berlin, 17th of november 2015
Allergy Course
“Targets for Prevention”

More Related Content

What's hot

Ensuring Child Health
Ensuring Child HealthEnsuring Child Health
Ensuring Child Healthjagchat01
 
2013 August - Pearls in Allergy and Immunology
2013 August - Pearls in Allergy and Immunology2013 August - Pearls in Allergy and Immunology
2013 August - Pearls in Allergy and ImmunologyJuan Aldave
 
Allergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergyAllergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergyAriyanto Harsono
 
How the Immune System Works
How the Immune System WorksHow the Immune System Works
How the Immune System WorksJohn Bergman
 
Vaccination history
Vaccination historyVaccination history
Vaccination historyJohn Bergman
 
Kearney Annual Review
Kearney Annual ReviewKearney Annual Review
Kearney Annual ReviewPreeyam Patel
 
Pearls in Allergy and Immunology October 2013
Pearls in Allergy and Immunology October 2013Pearls in Allergy and Immunology October 2013
Pearls in Allergy and Immunology October 2013Juan Aldave
 

What's hot (20)

Alpha-gal syndrome
Alpha-gal syndromeAlpha-gal syndrome
Alpha-gal syndrome
 
Ensuring Child Health
Ensuring Child HealthEnsuring Child Health
Ensuring Child Health
 
Latex allergy
Latex allergyLatex allergy
Latex allergy
 
Wheat allergy.
Wheat allergy.Wheat allergy.
Wheat allergy.
 
Oral allergy syndrome
Oral allergy syndromeOral allergy syndrome
Oral allergy syndrome
 
2013 August - Pearls in Allergy and Immunology
2013 August - Pearls in Allergy and Immunology2013 August - Pearls in Allergy and Immunology
2013 August - Pearls in Allergy and Immunology
 
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
 
Allergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergyAllergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergy
 
Peanut Allergy 2009
Peanut Allergy 2009Peanut Allergy 2009
Peanut Allergy 2009
 
How the Immune System Works
How the Immune System WorksHow the Immune System Works
How the Immune System Works
 
Food allergy from infancy through adulthood
Food allergy from infancy through adulthoodFood allergy from infancy through adulthood
Food allergy from infancy through adulthood
 
Vaccination history
Vaccination historyVaccination history
Vaccination history
 
Kearney Annual Review
Kearney Annual ReviewKearney Annual Review
Kearney Annual Review
 
Eosinophilic gastrointestinal disorders
Eosinophilic gastrointestinal disordersEosinophilic gastrointestinal disorders
Eosinophilic gastrointestinal disorders
 
Adverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 updateAdverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 update
 
Wheat allergy
Wheat allergyWheat allergy
Wheat allergy
 
Review Article
Review ArticleReview Article
Review Article
 
Atopic dermatitis: work in progress
Atopic dermatitis: work in progressAtopic dermatitis: work in progress
Atopic dermatitis: work in progress
 
Anti Ig E biologics and allergic diseases
Anti Ig E biologics and allergic diseasesAnti Ig E biologics and allergic diseases
Anti Ig E biologics and allergic diseases
 
Pearls in Allergy and Immunology October 2013
Pearls in Allergy and Immunology October 2013Pearls in Allergy and Immunology October 2013
Pearls in Allergy and Immunology October 2013
 

Viewers also liked

Best practice of allergen immunotherapy
Best practice of allergen immunotherapyBest practice of allergen immunotherapy
Best practice of allergen immunotherapyAriyanto Harsono
 
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme NHSNWRD
 
Format 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseasesFormat 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseasesEnvicon Medical Srl
 
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.Envicon Medical Srl
 
Format 2016: what is new in allergic & diseases respiratory 2016.
Format 2016:  what is new in allergic & diseases respiratory 2016.Format 2016:  what is new in allergic & diseases respiratory 2016.
Format 2016: what is new in allergic & diseases respiratory 2016.Envicon Medical Srl
 
Final dissertation
Final dissertationFinal dissertation
Final dissertationAlan McGeady
 
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".Жанна Подколзина
 

Viewers also liked (10)

Best practice of allergen immunotherapy
Best practice of allergen immunotherapyBest practice of allergen immunotherapy
Best practice of allergen immunotherapy
 
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme
Let's Talk Research 2015 - Joanna Harrison - CLAHRC NWC Internship scheme
 
Format 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseasesFormat 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseases
 
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
Format 2016: how to get asthma control: from PubMed to the tricks of the trade.
 
Format 2016: what is new in allergic & diseases respiratory 2016.
Format 2016:  what is new in allergic & diseases respiratory 2016.Format 2016:  what is new in allergic & diseases respiratory 2016.
Format 2016: what is new in allergic & diseases respiratory 2016.
 
Prevention of allergic diseases
Prevention of allergic diseasesPrevention of allergic diseases
Prevention of allergic diseases
 
Prevention of Allergic Diseases
Prevention of Allergic DiseasesPrevention of Allergic Diseases
Prevention of Allergic Diseases
 
Final dissertation
Final dissertationFinal dissertation
Final dissertation
 
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".
Марлен Дитрих и Мерлин Монро. Платья в стиле "NUDE".
 
ใบงานที่6 พชรพร
ใบงานที่6 พชรพรใบงานที่6 พชรพร
ใบงานที่6 พชรพร
 

Similar to Prevention in allergy

20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergicheAsmallergie
 
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...mothersafe
 
Use of Probiotics in the NICU
Use of Probiotics in the NICUUse of Probiotics in the NICU
Use of Probiotics in the NICUProlacta
 
Maternal Probiotics and Infant Eczema
Maternal Probiotics and Infant EczemaMaternal Probiotics and Infant Eczema
Maternal Probiotics and Infant EczemaKatherine Hoffman
 
1090904- 益生菌在兒童過敏疾病預防所扮演的角色
1090904- 益生菌在兒童過敏疾病預防所扮演的角色1090904- 益生菌在兒童過敏疾病預防所扮演的角色
1090904- 益生菌在兒童過敏疾病預防所扮演的角色Ks doctor
 
Probiotic administration in early life, atopy, and asthma, a meta analysis of...
Probiotic administration in early life, atopy, and asthma, a meta analysis of...Probiotic administration in early life, atopy, and asthma, a meta analysis of...
Probiotic administration in early life, atopy, and asthma, a meta analysis of...Ariyanto Harsono
 
&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방mothersafe
 
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsCell Science Systems
 
Evidence the use of probiotics in infants for prevention of allergic disease
Evidence the use of probiotics in infants for prevention of allergic diseaseEvidence the use of probiotics in infants for prevention of allergic disease
Evidence the use of probiotics in infants for prevention of allergic diseaseAriyanto Harsono
 
Effectiveness of vaccine dr. sharda
Effectiveness of vaccine dr. shardaEffectiveness of vaccine dr. sharda
Effectiveness of vaccine dr. shardaLifecare Centre
 
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...Lifecare Centre
 
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaEubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaNaturpharma (Medicina Biológica)
 
Edible vaccines-A new approach to oral immunization
Edible vaccines-A new approach to oral immunizationEdible vaccines-A new approach to oral immunization
Edible vaccines-A new approach to oral immunizationJagadabhi Ravinder Raju
 
AAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxAAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxhelvi6
 

Similar to Prevention in allergy (20)

20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche
 
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...
&lt;마더세이프라운드> Pregnancy outcome of women exposed to lactobacillus during preg...
 
Use of Probiotics in the NICU
Use of Probiotics in the NICUUse of Probiotics in the NICU
Use of Probiotics in the NICU
 
Maternal Probiotics and Infant Eczema
Maternal Probiotics and Infant EczemaMaternal Probiotics and Infant Eczema
Maternal Probiotics and Infant Eczema
 
POSTER
POSTERPOSTER
POSTER
 
1090904- 益生菌在兒童過敏疾病預防所扮演的角色
1090904- 益生菌在兒童過敏疾病預防所扮演的角色1090904- 益生菌在兒童過敏疾病預防所扮演的角色
1090904- 益生菌在兒童過敏疾病預防所扮演的角色
 
Probiotic administration in early life, atopy, and asthma, a meta analysis of...
Probiotic administration in early life, atopy, and asthma, a meta analysis of...Probiotic administration in early life, atopy, and asthma, a meta analysis of...
Probiotic administration in early life, atopy, and asthma, a meta analysis of...
 
&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방
 
Probiotics and children - a good mix?
Probiotics and children - a good mix?Probiotics and children - a good mix?
Probiotics and children - a good mix?
 
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactions
 
Evidence the use of probiotics in infants for prevention of allergic disease
Evidence the use of probiotics in infants for prevention of allergic diseaseEvidence the use of probiotics in infants for prevention of allergic disease
Evidence the use of probiotics in infants for prevention of allergic disease
 
Gbs
GbsGbs
Gbs
 
Effectiveness of vaccine dr. sharda
Effectiveness of vaccine dr. shardaEffectiveness of vaccine dr. sharda
Effectiveness of vaccine dr. sharda
 
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...
Effectiveness of the Influenza vaccine . Dr. Sharda Jain , Lifecare Cent...
 
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaEubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
 
Edible vaccines-A new approach to oral immunization
Edible vaccines-A new approach to oral immunizationEdible vaccines-A new approach to oral immunization
Edible vaccines-A new approach to oral immunization
 
AAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptxAAP_UNICEF_Neonatal_Sepsis.pptx
AAP_UNICEF_Neonatal_Sepsis.pptx
 
Probiotics 3 ecn
Probiotics 3 ecnProbiotics 3 ecn
Probiotics 3 ecn
 
Meningitis Vaccines
Meningitis VaccinesMeningitis Vaccines
Meningitis Vaccines
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 

Recently uploaded

VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowNehru place Escorts
 
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment BookingHousewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any TimeCall Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Timevijaych2041
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...narwatsonia7
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Serviceparulsinha
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 

Recently uploaded (20)

VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment BookingHousewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
 
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any TimeCall Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 

Prevention in allergy

  • 1. Prevention of allergy Where are we in 2015 ? Dr Masy Nadine European Exam in Allergology UEMS Examination EAACI Certificate of excellence in Allergology and Clinical Immunology Berlin, 17th of november 2015 Allergy Course “Targets for Prevention”
  • 2. The gut microbiota : in the early development of both local and systemic immune maturation and programming Studies on prevention : 1. The gut microbiota its localisation Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and DiseaseChristina L. Ohland1 and Christian Jobin1,2 (Cell Mol Gastroenterol Hepatol 2015;1:28–40
  • 3. Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and DiseaseChristina L. Ohland1 and Christian Jobin1,2 (Cell Mol Gastroenterol Hepatol 2015;1:28–40 Studies on prevention : 2. The gut microbiota and intestinal homeostasis
  • 4. The gut microbiota : in the early development of both local and systemic immune maturation and programming Studies on prevention : 3. The gut microbiota and fiber diet Increase in dietary fiber dampens allergic responses in the lung. Gary B Huffnagle. Nature Medicine 20, 120–121 (2014
  • 5. The immune system and the gut microbiota: friends or foes? N. Cerf-Bensussan, V.Gaboriau-Routhiau. Nature Reviews Immunology 10, 735-744 (October 2010) Studies on prevention : 4. The gut microbiota and altered host system
  • 6. Studies on prevention : 5. The gut microbiota of the pregnant woman Gut microbiota and allergy: the importance of the pregnancy period Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165 A possible route for bacteria originating from the gut to reach the placental tissue during pregnancy. Dendritic cells (DCs) actively penetrate the epithelium, sample the microbes within the gut lumen, and transport them to the placenta…
  • 7. Studies on prevention : 6. The gut microbiota of the pregnant woman Epigenetic changes of the promoter region of immunoregulatory genes important for allergy development could explain how the effect of microbial exposure to the mother during or even before pregnancy is transferred to the next generation… Gut microbiota and allergy: the importance of the pregnancy period Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165
  • 8. Studies on prevention : 7. The gut microbiota of the pregnant woman There is a temporal dissociation between the major changes in microbial exposure to children in westernized countries, which occurred during the first half of the century, and the onset of the accelerating increase in allergic diseases… Gut microbiota and allergy: the importance of the pregnancy period Thomas R. Abrahamsson, Richard You Wu, Maria C. Jenmalm Pediatric Research (2015) 77, 214–219 doi:10.1038/pr.2014.165
  • 9. Seventeen studies, reporting data from 4755 children (2381 in the probiotic group and 2374 in the control group) Infants treated with probiotics had a significantly lower RR for eczema compared to controls. No significant dif- ference in terms of prevention of asthma or rhinoconjunctivitis The results of the meta-analysis show that probiotic supplementation prevents infantile eczema, thus suggesting a new potential indication for probiotic use in pregnancy and infancy. Studies on prevention : 8. Probiotics started prenatally and in combination with breastfeeding and it is mainly probiotics started prenatally and in combination with breastfeeding, showing the best effectiveness Gut microbiota and allergy: the importance of the pregnancy period Zuccotti G, Meneghin F, Aceti A, Barone G, et al. Probiotics for prevention of atopic diseases in infants: systemic review and meta-analysis. Allergy 2015: 70: 1356–71.
  • 10. In a recent large meta-analysis performed on 25 trials, the authors concluded that a prenatal and/or early-life probi- otic Lactobacillus, Bifidobacterium, and Saccharomyces administration reduces the risk of atopic sensitization but may not reduce the risk of asthma/wheezing. Studies on prevention : 9. Probiotics started prenatally and in combination with breastfeeding Dugoua J-J, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta- analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can 2009;31:542–552.
  • 11. Studies on prevention : 10. Microbial exposure and colonization Promising candidates for allergy preventionJames E. Gern, MD, FAAAAIMadison, Wis J Allergy Clin Immunol 2015;136:23-8.)
  • 12. Studies on prevention : 11. Epigenetics and farm exposure in childhood Michel S, Busato F, Genuneit J, et al. Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy 2013;68:355–64. Farming seems to influence methylation in a number of the genes and gene families. It suggests the feasibility of such studies in asthma, and it highlights that a strong protective environmental factor, such as growing up on a farm, which is associated with disease development influences methylation and that timing of DNA collection for analysis is crucial
  • 13. Studies on prevention : 12. Early moisturizing in infants at risk for atopic dermatitis Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014: 134: 818–23.DU TEXTE DE
  • 14. Horimukai K, Morita K, Narita M, Kondo M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014: 134: 824– 30. Studies on prevention : 13. Early moisturizing in infants at risk for atopic dermatitis
  • 15. Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63. Effects of Vitreoscilla filiformis treatment on atopic dermatitis lesions. (Gram-negative aerobic bacterium) Patients treated (a)with placebo (b) with V. filiformis lysate before and on day 29 of treatment. Studies on prevention : 14. Early moisturizing with bacterial products
  • 16. Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63. Effects of Vitreoscilla filiformis treatment on pruritus. The mean visual analogue scale (VAS) score for pruritus by visit and treatment group with its 95% confidence interval. Compared with baseline a significant decrease was observed only in the V. filiformis group (verum), already by day 15 (P < 0·0002) and on day 29 (P < 0·0001). The between-group difference concerning pruritus VAS endpoint was also significant on day 29 (P = 0·017) as well as the course of pruritus development (the time by treatment interaction; P = 0·008). Studies on prevention : 15. Early moisturizing with bacterial products
  • 17. Gueniche A, Knaudt B, Schuck E, et al. Effects of non-pathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo- controlled clinical study. Br J Dermatol 2008: 159: 1357–63. Effects of Vitreoscilla filiformis treatment on SCORing of Atopic Dermatitis (SCORAD). Compared with baseline a significant decrease was observed only in the V. filiformis group (verum), Studies on prevention : 16. Early moisturizing with bacterial products
  • 18. Studies on prevention : 17. Studies on weaning Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008: 122: 984–91. In one study, it was found that the risk of peanut allergy was 10 times higher among Jewish children in UK, compared to Israeli children of similar ancestry, which was attributed to the early introduction of peanuts in the Israeli children
  • 19. Studies on prevention : 18. Studies on weaning : peanut Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008: 122: 984–91. UK UK ISRAEL
  • 20. Studies on prevention : 19. Studies on weaning : Israelic children Du Toit G, Katz Y, Sasieni P, et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008: 122: 984–91.
  • 21. Studies on prevention : 20. Studies on weaning : peanut consumption Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015: 372: 803–13. The British LEAP study (Learning Early About Peanut Allergy), 640 ‘high-risk’ babies (defined as those with egg allergy, severe eczema or both) The infants were assigned to two groups: those whose parents were to regularly feed them peanut and those whose parents were told to have their children avoid peanut altogether. The children, enrolled between the ages of 4 and 11 months, were given a conclusive peanut food challenge at age 5. At that age, on average, only 3.2% of the ‘consumption’ group had developed a peanut allergy, compared to more than 17.2% in the ‘avoidance’ group. They reported that in the peanut consumption group, at a high risk of developing allergy, showed a reduction of the odds that a peanut allergy will develop by a remarkable 70–80%. The results of the study have huge implications on the early introduction of allergic foods to prevent food allergy. YES NO
  • 22. Studies on prevention : 21. Guidelines of the AAAAI early peanut introduction J Allergy Clin Immunol 2015;136:258-61 The American Academy of Allergy, Asthma and Immunology (AAAAI) implemented the study in their new guidelines on allergy prevention
  • 23. Studies on prevention : 22. Early exposure to cow’s milk protein Katz Y, Rajuan N, Goldberg MR, et al. Early exposure to cow’s milk protein is protective against IgE-mediated cow’s milk protein allergy. J Allergy Clin Immunol 2010: 126: 77–82. Supplementation at birth with CMP (cow’s milk protein) should be recommended to promote its tolerance. For those patients with IgE- mediated CMP allergy, soy is a reasonable feeding alternative.
  • 24. Studies on prevention : 23. Studies on weaning : early egg introduction Palmer DJ, Metcalfe J, Makrides M, et al. Early regular egg exposure in infants with eczema: a randomized controlled trial. J Allergy Clin Immunol 2013: 132: 387–92.
  • 25. Studies on prevention : 24. Studies on weaning : early egg introduction Palmer DJ, Metcalfe J, Makrides M, et al. Early regular egg exposure in infants with eczema: a randomized controlled trial. J Allergy Clin Immunol 2013: 132: 387–92. Induction of immune tolerance pathways and reduction in the egg allergy rate can be achieved by early regular oral exposure to egg • from 4 months of age • in infants with moderate-to-severe eczema. The earlier introduction of egg in solid foods does not appear to increase the risk of egg allergy in this high-risk group. However, caution needs to be taken when these high-risk infants are first exposed to egg because many have sensitization already and clinical reactivity by 4 months of age. This points to much earlier events in the initiation of food sensitization, well before the introduction of complementary feeding. Clinical implications: Caution needs to be taken when infants with moderate-to- severe eczema are first exposed to egg because many have sensitization already and clinical reactivity by 4 months of age.
  • 26. Studies on prevention : 25. Studies on weaning : early egg introduction (Melbourne, Australia) Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13. the observational Australian HealthNuts study suggested that first exposure to more allergenic (unbaked) egg was more likely to reduce the egg allergy risk
  • 27. Studies on prevention : 26. Studies on weaning : early egg introduction (Melbourne, Australia) Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13.
  • 28. Studies on prevention : 27. Studies on weaning : early egg introduction (Melbourne, Australia) Koplin JJ, Osborne NJ, Wake M, Martin PE, Gurrin LC, Robinson MN, et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010;126:807-13. The observational Australian HealthNuts study suggested that first exposure to more allergenic (unbaked) egg was more likely to reduce the egg allergy risk In low-allergy risk infants Baked eggs : cake and biscuits Cooked eggs = hard-boiled,soft-boiled, fried or poached eggs
  • 29. Studies on prevention : 28. Studies on breastfeeding: Peroni DG, Pescollderungg L, PiacentiniGL, et al. Immune regulatory cytokines in the milk of lactating women from farming and urban environments. Pediatr Allergy Immunol 2010: 21: 977–82.
  • 30. Studies on prevention : 29. Studies on breastfeeding: Peroni DG, Pescollderungg L, PiacentiniGL, et al. Immune regulatory cytokines in the milk of lactating women from farming and urban environments. Pediatr Allergy Immunol 2010: 21: 977–82.
  • 31. Studies on prevention : 30. Studies on hypo-allergenic milks : • von Berg A, Filipiak-Pittroff B, Kramer U, Link E, et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008: 121: 1442–7.
  • 32. Studies on prevention : 31. Studies on hypo-allergenic milks : • Nieto A, Wahn U, Bufe A, Eigenmann P, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol 2014: 25: 516–33.
  • 33. Studies on prevention : 32. Studies on hypo-allergenic milks : Nieto A, Wahn U, Bufe A, Eigenmann P, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol 2014: 25: 516–33.
  • 34. Studies on prevention : 33. Studies on the gut microbiome in pregnancy: Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012: 150: 470–80. T1 Trimester 1 T3 Trimester 3
  • 35. Studies on prevention : 34. Studies on the gut microbiome in pregnancy: Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012: 150: 470–80. Actinobacteria (which includes Bifidobacteria) and Proteobacteria seem to undergo a significant distributive change in the last trimester of pregnancy, and it could be that focussing on Bifidobacteria is a better way to go Perhaps probiotics need to be started earlier in pregnancy (from the onset?), as the dynamics of the own microbiota, changing from the beginning of pregnancy, have been shown. Unfortunately, there are no comparative studies of microbiota during pregnancy between allergic and non-allergic women.
  • 36. Studies on prevention : 35. Studies on immunotherapy : Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized control trials. J Allergy Clin Immunol 2013: 132: 110–7.
  • 37. Studies on prevention : 36. Studies on immunotherapy : Prevention of New Sensitizations by Specific Immunotherapy in Children With Rhinitis and/or Asthma Monosensitized to House Dust Mite. J Investig Allergol Clin Immunol 2007; Vol. 17(2): 85-91 Effect on SIT on the medication score
  • 38. Studies on prevention : 37. Studies on food immunotherapy : OIT for peanut OIT can result in desensitisation in children, and that this is associated with evidence of underlying immune-modulation. However, this treatment approach was associated with a substantial risk of adverse events, although the majority of these were mild. In view of the risk of adverse events and the lack of evidence of long-term benefits, allergen-specific peanut OIT cannot currently be recommended as a treatment for the management of patients with IgE-mediated peanut allergy. Larger RCTs are needed to investigate the acceptability, long- term effectiveness and cost-effectiveness of safer treatment regimens, particularly in relation to the induction of clinical and immunological tolerance. Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012: 9: CD009014.
  • 39. Studies on prevention : 38. Studies on food immunotherapy : Tang ML, Ponsonby AL, Orsini F, et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol 2015: 135: 737–44. OIT for peanut and probiotics This is the first randomized placebo-controlled trial evaluating the novel co-administration of probiotic and peanut OIT and assessing for sustained unresponsiveness in children with peanut allergy. PPOIT was effective in inducing two-week sustained unresponsiveness, and immune changes that likely reflect reprogramming of the peanut- specific immune response. Further work is required to confirm sustained unresponsiveness after a longer period of secondary peanut elimination and to clarify the relative contributions of probiotic vs OIT.
  • 40. Studies on prevention : 39. Studies on immunotherapy : Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy, Volume 70, Issue 6, June 2015, Pages: 707–710, G. Senti, S. von Moos, F. Tay, N. Graf, P. Johansen and T. M. Kündig Epicutaneous immunotherapy Prior to the pollen season 2009, patients received six patches (allergen extract: n = 48; placebo: n = 50) with weekly intervals, administered onto tape-stripped skin. Allergen EPIT produced a median symptom improvement of 48% in 2009 and 40% in the treatment-free follow-up year 2010 as compared to 10% and 15% improvement after placebo EPIT (P = 0.003). After allergen EPIT but not placebo EPIT, conjunctival allergen reactivity was significantly decreased and allergen- specific IgG4 responses were significantly elevated (P < 0.001).
  • 41. Studies on prevention : 40. Studies on immunotherapy : Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model. Allergy, Volume 67, Issue 5, May 2012, Pages: 622–629, W. Li, Z. Zhang, A. Saxon and K. Zhang Epicutaneous immunotherapy with food in a mouse model Treg
  • 42. Mondoulet L, Dioszeghy V, Puteaux E, et al. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model. J Allergy Clin Immunol 2015: 135: 1546–57. Epicutaneous immunotherapy with food in a mouse model (EPIT) Treg Studies on prevention : 41. Studies on immunotherapy :
  • 43. Studies on prevention : 42. Studies on immunotherapy : Chang YC, Chow YH, Sun HL, et al. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein from Flammulina velutipes. Antiviral Res 2014: 110: 124–31. • Non-specific IT, using Th1 or Treg cell stimulants, such as bacterial antigens, should also become a subject of research in primary prevention. • One example is the anti-inflammatory and inhibitory effect on RSV replication of the golden needle mushroom (Flammulina velutipes) Non-specific immunotherapy using Th1 or Treg cell stimulants Non-specific immunotherapy FIP-fve proteinFlammulina velutipes
  • 44. Studies on prevention : 43. Studies on immunotherapy : Mpairwe H, Webb EL, Muhangi L, et al. Antihelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomized-controlled trial results. Pediatr Allergy Immunol 2011: 22: 305– 12. Non-specific immunotherapy , using immunomodulating agents like helminths during pregnancy Schistosoma mansoni Decreased risk of eczema in infants
  • 45. Studies on prevention : 44. Studies on immunotherapy : Mpairwe H, Webb EL, Muhangi L, et al. Antihelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomized-controlled trial results. Pediatr Allergy Immunol 2011: 22: 305– 12. Antihelminthic treatment of pregnant African mothers with Schistosoma mansoni Schistosoma mansoni Praziquantel Increased risk of eczema in infants Albendazole
  • 46. Studies on prevention : 45. Studies on immunotherapy : In utero priming by worms protects against respiratory allergies. Hermelijn H. Smits, Cezmi A. Akdis. Journal of Allergy and Clinical Immunology, Vol. 134, Issue 6, p 1280–1281 In utero priming by Schistosoma mansoni
  • 47. They are three types of primary prevention strategies - early administration of bacterial products (most studies are on probiotics) - early moisturizing in infants at risk for atopic dermatitis - early exposure to allergenic foods (studies are on milk,peanut and egg) - the use of immunotherapy - the use of immunomodulatory treatments (mushrooms proteins, worms products...)  much more research needs to be carried out  we have to define what advice can really be given in clinical practice Take home messages on prevention in allergy Berlin, 17th of november 2015 Allergy Course “Targets for Prevention”
  • 48. Thank you Dr Masy Nadine European Exam in Allergology UEMS Examination EAACI Certificate of excellence in Allergology and Clinical Immunology Berlin, 17th of november 2015 Allergy Course “Targets for Prevention”

Editor's Notes

  1. Dietary fiber is metabolized by the indigenous gut microbiota into SCFAs that can increase microbial diversity, dampen inflammatory pathways in macrophages and DCs, promote the development of Treg cells and serve as a growth factor for intestinal epithelium integrity and cellular health3, 4, 5. Trompette et al.6 now show that intestinal SCFAs enter the circulation and reach the bone marrow, where they enhance formation of precursors of DCs (hematopoiesis) and decrease activation of DCs from the circulation. short-chain fatty acids A new study in mice provides a link between dietary fiber intake, amounts of intestinal and systemic short-chain fatty acids, changes in the microbiome and allergic responses in the airways. The findings support the growing appreciation of a potential therapeutic role of diet in treating allergic diseases (pages 159–166). Increase in dietary fiber dampens allergic responses in the lung Gary B Huffnagle Nature Medicine 20, 120–121 (2014) doi:10.1038/nm.3472
  2. Figure 2. Microbial effects on the host. The microbiota induces host immune tolerance to commensal bacteria directly via a microbe-associated molecular pattern (MAMP) and polysaccharide (PSA) signaling, indirectly through the production of short- chain fatty acids (SCFA) and potentially through expression of epithelial intestinal alkaline phosphatase (IAP), which detoxifies luminal lipopolysaccharides (LPS). Furthermore, segmented filamentous bacteria (SFB) promote immune development of Th17 cells through epithelial cytokine production and antigen presentation by dendritic cells (DC), and the community as a whole is required for proper gut-associated lymphoid tissue (GALT) development. SCFA also induce IgA and mucus secretion into the lumen, promote epithelial barrier integrity, and prevent pathogen colonization. The microbiota also participates in the formation of the active, secondary forms of bile acids.
  3. Dietary fiber is metabolized by the indigenous gut microbiota into SCFAs that can increase microbial diversity, dampen inflammatory pathways in macrophages and DCs, promote the development of Treg cells and serve as a growth factor for intestinal epithelium integrity and cellular health3, 4, 5. Trompette et al.6 now show that intestinal SCFAs enter the circulation and reach the bone marrow, where they enhance formation of precursors of DCs (hematopoiesis) and decrease activation of DCs from the circulation. short-chain fatty acids A new study in mice provides a link between dietary fiber intake, amounts of intestinal and systemic short-chain fatty acids, changes in the microbiome and allergic responses in the airways. The findings support the growing appreciation of a potential therapeutic role of diet in treating allergic diseases (pages 159–166). Increase in dietary fiber dampens allergic responses in the lung Gary B Huffnagle Nature Medicine 20, 120–121 (2014) doi:10.1038/nm.3472
  4. a | In healthy hosts, an efficient immune barrier contains the microbiota in the gut lumen and feedback mechanisms avoid excessive activation of host immune responses. 'Peace-keeping' bacteria that release anti-inflammatory products participate in the tuning of host responses towards tolerance and help to prevent the pro-inflammatory effects of any pathobionts that are present in the microbiota, thus maintaining intestinal homeostasis. b | Immunodeficient patients, who lack an important component of the gut barrier (for example, secretory immunoglobulins in patients with common variable immunodeficiency (CVID)19) or a key regulatory pathway (for example, loss-of-function mutations that affect the interleukin-10 receptor (IL-10R)21) spontaneously develop intestinal inflammation when exposed to the microbiota. In more common forms of inflammatory bowel disease (IBD), a complex genetic background results in more subtle alterations of gut immune responses that may weaken the gut barrier and/or impair immunoregulation82. In these individuals, lifestyle changes or medical practices (for example, stress, diet, hygiene, smoking, antibiotics, vaccines or appendectomy) may promote the onset of gut inflammation by affecting the immune balance and/or the gut microbiota82. Intestinal inflammation results in increased bacterial adherence, epithelial damage and increased entry of bacteria into the intestinal lamina propria, thus sustaining a vicious inflammatory circle. Moreover, inflammation can favour the selection of aggressive pathobionts, which are more resistant to host-derived microbicidal mediators26, 27, and reduce the number of peace-keeping species16, which results in even more severe and uncontrolled inflammation. These pathobionts might become sufficiently aggressive to also cause disease in immunocompetent individuals43. ATG16L1, autophagy-related 16-like 1; IRGM, immunity-related GTPase family M; SCID, severe combined immunodeficient; TH cell, T helper cell; TReg cell, regulatory T cell.
  5. Limited microbial exposure is suggested to underlie the increase of allergic diseases in affluent countries, and bacterial diversity seems to be more important than specific bacteria taxa. Prospective studies indicate that the gut microbiota composition during the first months of life influences allergy development, and support the theory that factors influencing the early maturation of the immune system might be important for subsequent allergic disease. However, recent research indicates that microbial exposure during pregnancy may be even more important for the preventative effects against allergic disease. This review gives a background of the epidemiology, immunology, and microbiology literature in this field. It focuses on possible underlying mechanisms such as immune-regulated epigenetic imprinting and bacterial translocation during pregnancy, potentially providing the offspring with a pioneer microbiome. We suggest that a possible reason for the initial exposure of bacterial molecular patterns to the fetus in utero is to prime the immune system and/or the epithelium to respond appropriately to pathogens and commensals after birth.
  6. There is also evidence from human studies that prenatal microbial exposure results in immunoregulatory epigenetic modifications at birth. For instance, exposure to farms during pregnancy has been associated with increased DNA demeth- ylation of the Foxp3 locus in cord blood cells and enhanced neonatal regulatory T cell function (52), while the promoter regions of the Th2-associated genes RAD50 and IL-13 were hypermethylated in neonates from farming as compared with nonfarming families (53). In these studies, the exposure was confined to pregnancy, but epigenetic changes due to expo- sures early in life can persist to fertile age (54) and may pos- sibly be transferred to the next generation.
  7. Limited microbial exposure is suggested to underlie the increase of allergic diseases in affluent countries, and bacterial diversity seems to be more important than specific bacteria taxa. Prospective studies indicate that the gut microbiota composition during the first months of life influences allergy development, and support the theory that factors influencing the early maturation of the immune system might be important for subsequent allergic disease. However, recent research indicates that microbial exposure during pregnancy may be even more important for the preventative effects against allergic disease. This review gives a background of the epidemiology, immunology, and microbiology literature in this field. It focuses on possible underlying mechanisms such as immune-regulated epigenetic imprinting and bacterial translocation during pregnancy, potentially providing the offspring with a pioneer microbiome. We suggest that a possible reason for the initial exposure of bacterial molecular patterns to the fetus in utero is to prime the immune system and/or the epithelium to respond appropriately to pathogens and commensals after birth.
  8. Seventeen studies, reporting data from 4755 children (2381 in the probiotic group and 2374 in the control group), were included in the meta-analysis. Infants treated with probiotics had a significantly lower RR for eczema compared to controls (RR 0.78 [95% CI: 0.69–0.89], P = 0.0003), especially those supplemented with a mix- ture of probiotics (RR 0.54 [95% CI: 0.43–0.68], P < 0.00001). No significant dif- ference in terms of prevention of asthma (RR 0.99 [95% CI: 0.77–1.27], P = 0.95), wheezing (RR 1.02 [95% CI: 0.89–1.17], P = 0.76) or rhinoconjunctivi- tis (RR 0.91 [95% CI: 0.67–1.23], P = 0.53) was documented. The results of the present meta-analysis show that probiotic supplementation prevents infantile eczema, thus suggesting a new potential indication for probiotic use in pregnancy and infancy.
  9. Environmental sources of microbial colonization. The human microbiome evolves rapidly in the first few months of life, and microbial composition stabilizes by age 2 years. Many sources can contribute to colonization of the gastrointestinal tract, skin, and respiratory tract of the infant. During the perinatal period, maternal vaginal flora and skin flora, as well as mode of delivery, influence colonization. In early life other influences likely include airborne microbes that affect the upper and lower airways during respiration and are then swallowed. House dust and soil also contribute to microbial colonization, although in early life, house dust probably predominates in westernized societies. Pets can affect the home microbiome53 and, together with unwanted animals in the home (eg, mice and cockroaches),28 shape microbial exposures in the home. Ecological factors, such as temperature, humidity, and the amount of green space in a neighborhood, also affect microbial composition. In turn, babies eat dust and soil,54 a fact well documented in the toxicology liter- ature with respect to exposures to lead and other environmental toxins. Although current parenting customs seem to discourage ingestion of soil, in fact, this appears to be normal behavior for in- fants and could be an important source for establishment of the microbiome. Finally, food can influence microbes in the gastroin- testinal tract through several mechanisms; microbes present in or on foods can directly affect the gastrointestinal microbiome,26 GERNwhereas nutrient content can shape microbial content and composition.
  10. There is also evidence from human studies that prenatal microbial exposure results in immunoregulatory epigenetic modifications at birth. For instance, exposure to farms during pregnancy has been associated with increased DNA demeth- ylation of the Foxp3 locus in cord blood cells and enhanced neonatal regulatory T cell function (52), while the promoter regions of the Th2-associated genes RAD50 and IL-13 were hypermethylated in neonates from farming as compared with nonfarming families (53). In these studies, the exposure was confined to pregnancy, but epigenetic changes due to expo- sures early in life can persist to fertile age (54) and may pos- sibly be transferred to the next generation.
  11. Although not previously studied for primary prevention, emollient therapy plays an integral role in the management of established atopic dermatitis.29 The exact mechanisms through which emollients exert their positive effects are not completely understood. We propose that emollients correct subclinical skin barrier dysfunction and early inflammation in predisposed infants before atopic dermatitis development by improving skin hydra- tion and reducing skin permeability. This skin barrier enhance- ment prevents skin dryness and cracking, as well as inhibiting irritant and allergen penetration into the epidermis, which are po- tential initiators of skin inflammation.Future studies should address the potential for skin barrier protection to reduce IgE sensitization. Both human and mouse studies suggest that the skin barrier might be a site for IgE sensitization.30-32 If so, this approach might also represent a novel allergic asthma and food allergy prevention strategy. More data regarding the optimum emollients for atopic dermatitis preven- tion are also needed. Emollients should improve skin barrier func- tion, be free of irritants and potential allergens, and be low cost and easy to use so that the intervention can be used worldwide. It is unclear whether formulations that contain special additives, such as ceramides, improve the skin barrier or provide better clin- ical outcomes than simple petrolatum-based emollients.
  12. Primary prevention of allergic sensitizationSeveral cohort studies revealed that early-onset eczema increases the risk for allergic diseases, such as asthma, allergic rhinitis, and food allergy.10,11 The presence of AD was the main skin-related risk factor for food allergen sensitization in young infants.26 We confirmed that levels of anti–egg white and anti-ovomucoid IgEs measured by using a DLC chip correlate with those from CAP-FEIA. IgE-mediated egg allergy is one of the most common forms of food allergy; IgE against egg white is often used as a marker of atopy in infants.27,28 In our study we were not able to show the significant effect of emollient on the prevention of allergic sensitization based on the level of IgE antibody against egg white; similar proportions of infants were sensitized in the intervention and control groups. However, we showed that a higher proportion of infants with AD/eczema had allergic sensitization based on serum concentrations of anti–egg white IgE compared with infants without AD/eczema. Further- more, we found infants with skin lesions to have a more than 3-fold greater risk for allergic sensitization than infants without skin lesions based on 20 of 25 different cutoff points (range, 0.1-8.0 kUA/L CAP-FEIA equivalents). Collectively, these findings indicate that the presence of eczematous skin, rather than a lack of emollient use, induces or promotes sensitization to allergens, such as egg white, during the first 8 months of life.The mechanisms of this process are unclear. Levels of tight junction proteins (eg, claudin-1) between epidermal cells are significantly decreased in patients with AD compared with those seen in nonatopic subjects.29 Also, Langerhans cells were reported to elongate their dendrites, penetrate keratinocyte tight junctions, and take up antigens when the Langerhans cells were activated by means of tape stripping.30 These results could provide information on how eczematous skin promotes allergen sensitization.Future directionsFindings from our RCT support our hypothesis that daily application of a moisturizer would prevent development of AD/eczema during the first 32 weeks of life. Contrary to our hypothesis, however, allergic sensitization, as assessed on the basis of acquisition of anti–egg white IgE, was not affected by application of the emollient. Our post hoc analysis revealed that the incidence of allergic sensitization was significantly increased among infants with skin lesions, including those caused by AD/eczema, compared with that seen in infants without these lesions. However, studies of a larger number of subjects might find that moisturizer use reduces allergic sensitization by preventing development of AD/eczema. In this post hoc analysis skin rash that did not fulfill the present criteria for AD/eczema, such as a lack of pruritus, was proposed to contribute to allergen sensitization. Allergic sensitization sometimes precedes and predicts the development of eczema,31 and we have described the presence of low-affinity IgE against food antigens in blood and cord blood samples from newborns.32 Therefore further studies should examine whether sensitization might occur through the placenta or neonatal gastrointestinal tract. It will be interesting to examine the temporal sequence of allergic sensitization, especially of epicutaneous sensitization to food antigens, by separately measuring levels of low-affinity and ordinary IgEs against food Clinical implications: Daily application of emollient reduces the risk of AD/eczema by 32 weeks. We might be able to reduce the prevalence of allergic sensitization by preventing the develop- ment of AD/eczema.
  13. We performed a prospective, double-blind, placebo-controlled clinical study with a cream containing a 5% lysate of the nonpathogenic bacteria Vitreoscilla filiformis. Seventy-five volunteers with AD (6-70 years of age) were randomized to receive either V. filiformis cream 5% or vehicle cream daily for 30 days. Efficacy was evaluated by the SCORe of Atopic Dermatitis (SCORAD), transepidermal water loss (TEWL), assessment of microflora, and the patient's assessment of itch and loss of sleep. Compared with placebo, V. filiformis lysate significantly decreased SCORAD levels (P=0.0044) and pruritus (P=0.0171). Active cream significantly decreased loss of sleep from day 0 to day 29 (P=0.0074). Qualitative and quantitative assessment of cutaneous microbial colonization revealed that V. filiformis lysate reduced Staphylococcus aureus colonization of the skin. The skin barrier as determined by TEWL also improved significantly with the cream alone. V. filiformis lysate significantly improved AD. This may be in part due to reduction of S. aureus, but seems to relate in most parts to a direct immunomodulatory effect on skin-associated immune responses.
  14. We performed a prospective, double-blind, placebo-controlled clinical study with a cream containing a 5% lysate of the nonpathogenic bacteria Vitreoscilla filiformis. Seventy-five volunteers with AD (6-70 years of age) were randomized to receive either V. filiformis cream 5% or vehicle cream daily for 30 days. Efficacy was evaluated by the SCORe of Atopic Dermatitis (SCORAD), transepidermal water loss (TEWL), assessment of microflora, and the patient's assessment of itch and loss of sleep. Compared with placebo, V. filiformis lysate significantly decreased SCORAD levels (P=0.0044) and pruritus (P=0.0171). Active cream significantly decreased loss of sleep from day 0 to day 29 (P=0.0074). Qualitative and quantitative assessment of cutaneous microbial colonization revealed that V. filiformis lysate reduced Staphylococcus aureus colonization of the skin. The skin barrier as determined by TEWL also improved significantly with the cream alone. V. filiformis lysate significantly improved AD. This may be in part due to reduction of S. aureus, but seems to relate in most parts to a direct immunomodulatory effect on skin-associated immune responses.
  15. Figure 4 Effects of Vitreoscilla filiformis treatment on SCORing of Atopic Dermatitis (SCORAD). Depicted is the mean SCORAD by visit and treatment group with its 95% confidence interval. Compared with baseline a significant decrease was observed only in the V. filiformis group (verum), already by day 15 (P < 0·0001) and on day 29 (P < 0·0001). The between-group difference in SCORAD endpoint was also significant on day 29 (P = 0·004) as well as the course of SCORAD development (the time by treatment interaction; P = 0·0014). We performed a prospective, double-blind, placebo-controlled clinical study with a cream containing a 5% lysate of the nonpathogenic bacteria Vitreoscilla filiformis. Seventy-five volunteers with AD (6-70 years of age) were randomized to receive either V. filiformis cream 5% or vehicle cream daily for 30 days. Efficacy was evaluated by the SCORe of Atopic Dermatitis (SCORAD), transepidermal water loss (TEWL), assessment of microflora, and the patient's assessment of itch and loss of sleep. Compared with placebo, V. filiformis lysate significantly decreased SCORAD levels (P=0.0044) and pruritus (P=0.0171). Active cream significantly decreased loss of sleep from day 0 to day 29 (P=0.0074). Qualitative and quantitative assessment of cutaneous microbial colonization revealed that V. filiformis lysate reduced Staphylococcus aureus colonization of the skin. The skin barrier as determined by TEWL also improved significantly with the cream alone. V. filiformis lysate significantly improved AD. This may be in part due to reduction of S. aureus, but seems to relate in most parts to a direct immunomodulatory effect on skin-associated immune responses.
  16. Concernant plus précisément l’allergie à l’arachide, l’équipe londonienne de Gideon Lack a publié il y a quelques années les résultats d’une étude comparant sa fréquence en Israël -0,11% -, et dans la communauté juive d’Angleterre - 1,54%- c’est-à-dire 15 fois plus fréquente. Dans le même temps, ils ont analysé la consommation de l’arachide chez les nourrissons et montré que 81 % des petits israéliens consommaient au moins six grammes de protéine d’arachide chaque semaine avant l’âge de un an, alors que 78 % des petits anglais n’en consommaient pas, en accord avec les recommandations de ce pays. Par conséquent, sur un terrain génétique commun, on notait une prévalence très différente de l’allergie à l’arachide, potentiellement liée au mode d’alimentation.
  17. Elles viennent d’une publication récente par une équipe anglaise: Randomized trial of peanut consumption in infants at risk for peanut allergy. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez Lorenzo M, Plaut M, Lack G; LEAP Study Team. N Engl J Med. 2015 Feb 26;372(9):803-13. L’allergie alimentaire est devenue un problème de santé publique touchant selon les pays d’Europe 0,1 % à 6% de la population pour les aliments courants. En France, on estime que 4 à 5 % des enfants sont confrontés à l’allergie alimentaire, et que l’allergie à l’arachide touche 0,3 à 0,75 % de la population.Le contexte de l’étudeJusqu’à nouvel ordre, on ne dispose pas de stratégie pour prévenir l’allergie alimentaire ni plus précisément celle à l’arachide. L’éviction des aliments allergisants, notamment de l’arachide pendant la grossesse ou pendant l’allaitement, n’est plus recommandée, celle-ci pouvant même renforcer le risque de survenue d’une allergie. Les recommandations actuelles sont de différer au-delà de l’âge de 1 an l’introduction des aliments les plus à risque dont l’arachide.Concernant plus précisément l’allergie à l’arachide, l’équipe londonienne de Gideon Lack a publié il y a quelques années les résultats d’une étude comparant sa fréquence en Israël -0,11% -, et dans la communauté juive d’Angleterre - 1,54%- c’est-à-dire 15 fois plus fréquente. Dans le même temps, ils ont analysé la consommation de l’arachide chez les nourrissons et montré que 81 % des petits israéliens consommaient au moins six grammes de protéine d’arachide chaque semaine avant l’âge de un an, alors que 78 % des petits anglais n’en consommaient pas, en accord avec les recommandations de ce pays. Par conséquent, sur un terrain génétique commun, on notait une prévalence très différente de l’allergie à l’arachide, potentiellement liée au mode d’alimentation.Les mêmes auteurs ont montré que les nourrissons qui présentaient un eczéma sévère, et/ou une allergie vis-à-vis de l’œuf avaient un risque très important de développer secondairement une allergie à l’arachide. Sur ce constat, Gideon Lack et son équipe ont bâti l’étude LEAP («  Learning Early about Peanut Allergy ») dont l’objectif était d’analyser si l’introduction précoce de l’arachide dans l’alimentation  pouvait protéger les enfants à risque de développer une allergie à l’arachide. Les résultats sont rapportés par Georges Du Toit dans un numéro récent du New England Journal of Medicine.L’étude640 nourrissons âgés de 4 à 11 mois et présentant tous une dermatite atopique sévère et/ou une allergie à l’œuf ont été inclus. Ces nourrissons avaient par ailleurs un test cutané (prick test) négatif ou faiblement positif (< 4 mm) pour  l’arachide. Par tirage au sort, le régime de ces nourrissons a été déterminé : consommation  ou non de l’arachide.  En cas de consommation, on demandait aux parents de donner chaque semaine au moins six grammes de protéine d’arachide sous la forme de snack Bamba (proche du Curly) ou de beurre de cacahuètes. Pour les autres, l’éviction était maintenue. Les enfants et leur famille étaient ensuite suivis régulièrement, par téléphone et en consultation jusque l’âge de 5 ans.Les résultatsA l’âge de cinq ans, on déterminait le pourcentage d’enfants réellement allergiques à la cacahuète par le biais d’un test de provocation orale. II faut souligner que 98 % des patients ont été évalués à l’âge de cinq ans, et que le protocole a pu être réalisé correctement chez 92 % d’entre eux. Parmi les 530 enfants ayant initialement un test cutané négatif, 13,7 % ayant maintenu l’éviction étaient allergiques contre 1,9 % seulement dans le groupe ayant consommé régulièrement de l’arachide (réduction du risque de 86%). Parmi les 98 patients ayant initialement un test cutané légèrement positif, 36,3 % de ceux ayant poursuivi l’éviction étaient allergiques contre 10,6 % dans le groupe ayant consommé de l’arachide (réduction du risque de 70%).Quels sont les messages de cette étude ?Pour la première fois, une étude conduite selon une méthodologie solide montre qu’il est possible de prévenir une allergie alimentaire potentiellement sévère chez des patients qui ne sont pas encore ou faiblement sensibilisés mais n’ont pas développé de symptômes d’allergie. Ces résultats sont de surcroît obtenus chez des enfants pour lesquels il existe un fort potentiel de développer une allergie à l’arachide.Cette protection est obtenue à condition de consommer précocement de l’arachide, dès la première année de vie. Cette proposition bouscule donc  les recommandations actuelles ! Les résultats spectaculaires de ce travail devront être confirmés sur d’autres populations, dans d’autres pays.Et maintenant ?En pratique courante, il n’est pas (encore) question de  «libérer » la consommation d’arachide chez tous les nourrissons, a fortiori ceux à risque de développer une allergie, sans quelques règles qu’il faut rappeler ! Et d’abord que cet aliment dans sa forme native peut aussi être accidentellement inhalé … avec des conséquences potentiellement graves.
  18. The role of early oral exposure to dietary proteins in rendering tolerance is gaining recognition.30 The exact timing and mecha- nism by which this tolerance occurs is still poorly understood.31,32 It is possible that different proteins have varying patterns of toler- ance versus sensitization and allergenic timing.33 Introduction of peanuts at the age of 6 to 8 months, for example, appears to induce tolerance,34 whereas in our study milk tolerance appears to be in- duced by its introduction at an earlier age. A similar idea was re- ported previously,35 but those findings were not integrated into common practice. The idea of the protective effect of early oral introduction of protein was suggested more than 25 years ago by Jarret.36 Our study provides large-scale, prospective clinical evidence to support this hypothesis. Therefore we cannot rule82 KATZ ET ALout that some infants with very mild clinical reactions were con- tinued to be fed CMP and developed tolerance who otherwise would have eventually had clinically significant IgE-CMA. Fi- nally, a limitation of this study is the lack of information on the amount of CMP that has to be introduced to prevent IgE-CMA.The data should not be interpreted as discouraging breast- feeding. The great advantages of breast-feeding in providing essential nutrients and immunomodulatory effects are well appreciated. Therefore it seems reasonable to consider early complementary feeding of CMP along with breast-feeding to promote oral tolerance, especially in high-risk infants.
  19. FIG 3. IgE/IgG4 ratios at 12 months of age in infants with IgE-mediated egg allergy compared with those seen in infants who tolerated the egg chal- lenge. For infants with IgE-mediated egg allergy, the median IgE/IgG4 ratio in the egg group was 15.90 (IQR, 4.03-56.86), and that in the control group was 15.75 (IQR, 6.42-110.63). For infants who tolerated the egg challenge, the median IgE/IgG4 ratio in the egg group was 0.09 (IQR, 0.02-0.43), and that in the control group was 1.43 (IQR, 0.48-1.43). A randomized controlled study from Australia evaluated early introduction of egg in high-risk infants with AD (egg was introduced daily from age 4 to 8 months), looking at the timing of egg introduction into the infant’s diets, and whether it was related to egg allergy in early childhood (25). A high proportion (31%) of infants randomized to receive egg had an allergic reaction to the egg powder and did not continue powder ingestion. At 4 months of age, before any known egg ingestion, 36% of infants already had egg-specific IgE levels (>0.35 kU/l). The authors concluded that children introduced to egg in the first 12 months of life were 51% less likely to have a confirmed or suspected egg allergy at 1 year of age (5.2% vs. 11.5%, RR 0.49, 95% CI, 0.25–0.97, p < 0.05) and 48% less likely to have a confirmed or suspected egg allergy between 1 and 3 years of age (7.0% vs. 14.5%, RR 0.52, 95% CI, 0.28– 0.98, p < 0.05). Egg exposure in the first year of life did not predict egg sensitization (i.e. a positive skin prick test to egg) at any age. There was also no significant association between egg exposure in the first 12 months and AD with egg sensitization at either 1 year of age or at one or three years of age.
  20. FIG 3. IgE/IgG4 ratios at 12 months of age in infants with IgE-mediated egg allergy compared with those seen in infants who tolerated the egg chal- lenge. For infants with IgE-mediated egg allergy, the median IgE/IgG4 ratio in the egg group was 15.90 (IQR, 4.03-56.86), and that in the control group was 15.75 (IQR, 6.42-110.63). For infants who tolerated the egg challenge, the median IgE/IgG4 ratio in the egg group was 0.09 (IQR, 0.02-0.43), and that in the control group was 1.43 (IQR, 0.48-1.43). A randomized controlled study from Australia evaluated early introduction of egg in high-risk infants with AD (egg was introduced daily from age 4 to 8 months), looking at the timing of egg introduction into the infant’s diets, and whether it was related to egg allergy in early childhood (25). A high proportion (31%) of infants randomized to receive egg had an allergic reaction to the egg powder and did not continue powder ingestion. At 4 months of age, before any known egg ingestion, 36% of infants already had egg-specific IgE levels (>0.35 kU/l). The authors concluded that children introduced to egg in the first 12 months of life were 51% less likely to have a confirmed or suspected egg allergy at 1 year of age (5.2% vs. 11.5%, RR 0.49, 95% CI, 0.25–0.97, p < 0.05) and 48% less likely to have a confirmed or suspected egg allergy between 1 and 3 years of age (7.0% vs. 14.5%, RR 0.52, 95% CI, 0.28– 0.98, p < 0.05). Egg exposure in the first year of life did not predict egg sensitization (i.e. a positive skin prick test to egg) at any age. There was also no significant association between egg exposure in the first 12 months and AD with egg sensitization at either 1 year of age or at one or three years of age.
  21. *Numbers in each analysis differ because of missing data. Adjusted OR based on logistic regression model adjusted for family history of allergy, eczema diagnosis before the introduction of egg, and parent-reported reactions to 1 or more foods in the infant. "Adjusted OR based on logistic regression model adjusted for family history of allergy, age at introduction of egg, duration of breast-feeding, maternal smoking during pregnancy, parents’ country of birth, and eczema diagnosis before the introduction of solids. §Adjusted OR based on logistic regression model adjusted for family history of allergy, maternal consumption of egg during breast-feeding, maternal smoking during pregnancy, and eczema diagnosis before ceasing breast-feeding. In conclusion, our results have major implications for both practice and future research. Our data strongly suggest that introducing cooked egg at 4 to 6 months of age might protect against egg allergy and that delaying introduction to 10 to 12 months of age might in fact exacerbate it. Confirmation that early introduction is protective might result in radical changes in infant feeding guidelines and have the potential to reverse the epidemic of childhood food allergy. A randomized controlled study from Australia evaluated early introduction of egg in high-risk infants with AD (egg was introduced daily from age 4 to 8 months), looking at the timing of egg introduction into the infant’s diets, and whether it was related to egg allergy in early childhood (25). A high proportion (31%) of infants randomized to receive egg had an allergic reaction to the egg powder and did not continue powder ingestion. At 4 months of age, before any known egg ingestion, 36% of infants already had egg-specific IgE levels (>0.35 kU/l). The authors concluded that children introduced to egg in the first 12 months of life were 51% less likely to have a confirmed or suspected egg allergy at 1 year of age (5.2% vs. 11.5%, RR 0.49, 95% CI, 0.25–0.97, p < 0.05) and 48% less likely to have a confirmed or suspected egg allergy between 1 and 3 years of age (7.0% vs. 14.5%, RR 0.52, 95% CI, 0.28– 0.98, p < 0.05). Egg exposure in the first year of life did not predict egg sensitization (i.e. a positive skin prick test to egg) at any age. There was also no significant association between egg exposure in the first 12 months and AD with egg sensitization at either 1 year of age or at one or three years of age.
  22. *Numbers in each analysis differ because of missing data. Adjusted OR based on logistic regression model adjusted for family history of allergy, eczema diagnosis before the introduction of egg, and parent-reported reactions to 1 or more foods in the infant. "Adjusted OR based on logistic regression model adjusted for family history of allergy, age at introduction of egg, duration of breast-feeding, maternal smoking during pregnancy, parents’ country of birth, and eczema diagnosis before the introduction of solids. §Adjusted OR based on logistic regression model adjusted for family history of allergy, maternal consumption of egg during breast-feeding, maternal smoking during pregnancy, and eczema diagnosis before ceasing breast-feeding. In conclusion, our results have major implications for both practice and future research. Our data strongly suggest that introducing cooked egg at 4 to 6 months of age might protect against egg allergy and that delaying introduction to 10 to 12 months of age might in fact exacerbate it. Confirmation that early introduction is protective might result in radical changes in infant feeding guidelines and have the potential to reverse the epidemic of childhood food allergy. A randomized controlled study from Australia evaluated early introduction of egg in high-risk infants with AD (egg was introduced daily from age 4 to 8 months), looking at the timing of egg introduction into the infant’s diets, and whether it was related to egg allergy in early childhood (25). A high proportion (31%) of infants randomized to receive egg had an allergic reaction to the egg powder and did not continue powder ingestion. At 4 months of age, before any known egg ingestion, 36% of infants already had egg-specific IgE levels (>0.35 kU/l). The authors concluded that children introduced to egg in the first 12 months of life were 51% less likely to have a confirmed or suspected egg allergy at 1 year of age (5.2% vs. 11.5%, RR 0.49, 95% CI, 0.25–0.97, p < 0.05) and 48% less likely to have a confirmed or suspected egg allergy between 1 and 3 years of age (7.0% vs. 14.5%, RR 0.52, 95% CI, 0.28– 0.98, p < 0.05). Egg exposure in the first year of life did not predict egg sensitization (i.e. a positive skin prick test to egg) at any age. There was also no significant association between egg exposure in the first 12 months and AD with egg sensitization at either 1 year of age or at one or three years of age.
  23. ND, Not determined. *Low-allergy-risk infants were defined as those without a family history of food allergy and with no history of eczema or parent-reported reactions to foods in the infant. High-allergy-risk infants were defined as those with 1 or more of the following: a family history of food allergy, a history of eczema in the infant, or a parent-reported reaction to 1 or more foods in the infant. In conclusion, our results have major implications for both practice and future research. Our data strongly suggest that introducing cooked egg at 4 to 6 months of age might protect against egg allergy and that delaying introduction to 10 to 12 months of age might in fact exacerbate it. Confirmation that early introduction is protective might result in radical changes in infant feeding guidelines and have the potential to reverse the epidemic of childhood food allergy. A randomized controlled study from Australia evaluated early introduction of egg in high-risk infants with AD (egg was introduced daily from age 4 to 8 months), looking at the timing of egg introduction into the infant’s diets, and whether it was related to egg allergy in early childhood (25). A high proportion (31%) of infants randomized to receive egg had an allergic reaction to the egg powder and did not continue powder ingestion. At 4 months of age, before any known egg ingestion, 36% of infants already had egg-specific IgE levels (>0.35 kU/l). The authors concluded that children introduced to egg in the first 12 months of life were 51% less likely to have a confirmed or suspected egg allergy at 1 year of age (5.2% vs. 11.5%, RR 0.49, 95% CI, 0.25–0.97, p < 0.05) and 48% less likely to have a confirmed or suspected egg allergy between 1 and 3 years of age (7.0% vs. 14.5%, RR 0.52, 95% CI, 0.28– 0.98, p < 0.05). Egg exposure in the first year of life did not predict egg sensitization (i.e. a positive skin prick test to egg) at any age. There was also no significant association between egg exposure in the first 12 months and AD with egg sensitization at either 1 year of age or at one or three years of age.
  24. It is also worth mentioning that breastfeeding is still first choice in preventing allergy and that studies are needed to improve the anti-allergic effects of breast milk, which seem to be dependent of immunomodulating substances, including TGF-a and IgA (= PROTECTIVE ON ATOPY DVPT)
  25. It is also worth mentioning that breastfeeding is still first choice in preventing allergy and that studies are needed to improve the anti-allergic effects of breast milk, which seem to be dependent of immunomodulating substances, including TGF-a and IgA (= PROTECTIVE ON ATOPY DVPT) Fig. 3. Individual values of TGF-b1 in colostrum and mature milk of allergic (22 between reference and 10 between farm mothers) and non-allergic mothers (43 between reference and 35 between farm mothers).
  26. The role of hypo-allergenic (HA) milks (i.e. extensively or partially hydrolysed) in primary prevention also needs further attention and more study and is another interesting field of research (especially in mothers who are unable to breastfeed), as suggested by their preventive effect upon AD in the GINI study and in others
  27. Somespecificinterventions in nutritional factors have shown to prevent some allergic diseases while others have not. We are still lacking evidence that microbial interventions can induce a more global healthy immune response. +: Beneficial effects observed Ø: Beneficial effects not observed; ?: Inconclusive results or unexplored
  28. Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012: 150: 470–80. CYTOKINES PRO-INFLAMMATOIRES Many of the immune and metabolic changes occurring during normal pregnancy also describe metabolic syndrome. Gut microbiota can cause symptoms of metabolic syndrome in nonpregnant hosts. Here, to explore their role in pregnancy, we characterized fecal bacteria of 91 pregnant women of varying prepregnancy BMIs and gestational diabetes status and their infants. Similarities between infant-mother microbiotas increased with children's age, and the infant microbiota was unaffected by mother's health status. Gut microbiota changed dramatically from first (T1) to third (T3) trimesters, with vast expansion of diversity between mothers, an overall increase in Proteobacteria and Actinobacteria, and reduced richness. T3 stool showed strongest signs of inflammation and energy loss; however, microbiome gene repertoires were constant between trimesters. When transferred to germ-free mice, T3 microbiota induced greater adiposity and insulin insensitivity compared to T1. Our findings indicate that host-microbial interactions that impact host metabolism can occur and may be beneficial in pregnancy.
  29. Koren O, Goodrich JK, Cullender TC, Spor A, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012: 150: 470–80.
  30. Although our study has several limitations, we demonstrated a statistically significant benefit of allergen-SIT for patients with atopic dermatitis, based on data pooled from 8 RCTs (385 patients). Our results provide physicians with the evidence necessary to consider allergen-SIT for patients with atopic dermatitis, especially those with severe uncontrolled disease. This meta-analysis presents moderate-quality evidence, and further research could influence our confidence in this ap- proach.36 Additional well-designed, double-blind RCTs are needed to confirm the efficacy of SIT; more long-term informa- tion is needed to verify that SIT is a disease-modifying therapyJ ALLERGY CLIN IMMUNOL VOLUME 132, NUMBER 1for atopic dermatitis. It will also be essential to learn the precise immune mechanisms of allergen-SIT in atopic dermatitis. Statis- tical differences may not be of clinical relevance, and more crit- ical issues such as cost-benefit and patient compliance must be evaluated in the clinical field.
  31. Dissection of the potential mechanisms involved in allergen tolerance induced by allergen skin application. Skin histopathology of the sites painted with various doses of complete peanut extract (CPE). (B) Cytokine responses in the local and distal draining lymph notes by CPE skin application. The statistical differences between different groups wereindicated with asterisks (*P < 0.05; **P < 0.01). (C) Treg inductionfrom the local draining inguinal lymph node (ILN) upon allergen skin application (*P < 0.05). (D) Migratory Langerhans cells induction from the local ILN upon allergen skin application (*P < 0.05). The shown results are the representative of four similar experiments.
  32. Sham = placebo epicutaneous patch EPIT-induced methylation of the GATA-3 promoter. Methylation levels of transcription factor promoters (GATA-3 and T-bet) were investigated in the negative control, sham, and EPIT groups. A, GATA-3 methylation status immediately after the end of milk EPIT. B, T-bet methylation status just after the end of milk EPIT. C, GATA-3 methylation status after the second period of sensitization to peanut. D, T-bet methylation status after the second period of sensitization to peanut. Values are expressed as means 6 SDs. *P < .05.
  33. FIP-fve protein (2 differents parts in one protein) https://commons.wikimedia.org/wiki/File:FIP-fve_protein.png •Apart from allergen IT, non-specific IT, using Th1 or Treg cell stimulants, such as bacterial antigens, should also become a subject of research in primary prevention. One example is the anti-inflammatory and inhibitory effect on RSV replication of the golden needle mushroom (Flammulina velutipes)
  34. We have shown for the first time that treatment of pregnant women with albendazole is associated with increased risk of infantile eczema and that treatment with praziquantel is associated with increased risk of eczema among infants of mothers with S. mansoni infection. Our findings are consis- tent with our preliminary study (17) and support the hypothesis that maternal worms during pregnancy, or neo- natal life and early breastfeeding, may protect against allergy in infancy and that treatment of these worms during pregnancy increases the risk of allergy. The effects of treat- ment on reported allergy outcomes at 1 yr were similar to those for doctor-diagnosed outcomes, suggesting good inter- nal validity of the study. These results may be generalised to communities with similar prevalence and intensity of worm infections. In research on IT, the adjuvant effect of helminths or helminthic proteins, as immunomodulating agents, deserves further study, as it was found that in early life helminths are able to induce strong regulatory mechanisms. In a clinical study, antihelminthic treatment of Ugandan mothers increased the prevalence of infantile AD and wheezing compared with seen in a placebo-controlled group (40)
  35. We have shown for the first time that treatment of pregnant women with albendazole is associated with increased risk of infantile eczema and that treatment with praziquantel is associated with increased risk of eczema among infants of mothers with S. mansoni infection. Our findings are consis- tent with our preliminary study (17) and support the hypothesis that maternal worms during pregnancy, or neo- natal life and early breastfeeding, may protect against allergy in infancy and that treatment of these worms during pregnancy increases the risk of allergy. The effects of treat- ment on reported allergy outcomes at 1 yr were similar to those for doctor-diagnosed outcomes, suggesting good inter- nal validity of the study. These results may be generalised to communities with similar prevalence and intensity of worm infections. In research on IT, the adjuvant effect of helminths or helminthic proteins, as immunomodulating agents, deserves further study, as it was found that in early life helminths are able to induce strong regulatory mechanisms. In a clinical study, antihelminthic treatment of Ugandan mothers increased the prevalence of infantile AD and wheezing compared with seen in a placebo-controlled group (40)
  36. FIG 1. Immune responses provoked by maternal worm infections can protect offspring against the development of allergic airway inflammation after birth, depending on the infection phase. Offspring was protected when schistosome-infected mothers were mated in the TH1 (prepatent larval infection) or regulatory (chronic infection) but not the TH2 (acute infection) immune phase. Mating of IFN-g–deficient, initial TH1 phase–in- fected mothers with wild-type fathers yielded susceptible offspring for allergic airway inflammation, confirming that maternal IFN-g was crucial for inducing protection in the offspring. This study provides an explanation for discrepancies in epidemiologic studies showing a variable degree of allergy or protection in children born to worm-infected mothers.
  37. Van Bever HP, Nagarajan S, Shek LP, Lee B-W. OPINION: Primary prevention of allergy – Will it soon become a reality? Pediatr Allergy Immunol. 2016: 27: 6–12.
  38. Van Bever HP, Nagarajan S, Shek LP, Lee B-W. OPINION: Primary prevention of allergy – Will it soon become a reality? Pediatr Allergy Immunol. 2016: 27: 6–12.